KR890012636A - 다층 과립 - Google Patents

다층 과립 Download PDF

Info

Publication number
KR890012636A
KR890012636A KR1019890001165A KR890001165A KR890012636A KR 890012636 A KR890012636 A KR 890012636A KR 1019890001165 A KR1019890001165 A KR 1019890001165A KR 890001165 A KR890001165 A KR 890001165A KR 890012636 A KR890012636 A KR 890012636A
Authority
KR
South Korea
Prior art keywords
release layer
layer
intermediate layer
rapid
releasing layer
Prior art date
Application number
KR1019890001165A
Other languages
English (en)
Other versions
KR910004582B1 (ko
Inventor
시게루 아오끼
게이조오 우에스기
시게루 사까시다
마사요시 가사이
마사노리 가야노
Original Assignee
나이또오 하루오
에자이 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나이또오 하루오, 에자이 가부시끼가이샤 filed Critical 나이또오 하루오
Publication of KR890012636A publication Critical patent/KR890012636A/ko
Application granted granted Critical
Publication of KR910004582B1 publication Critical patent/KR910004582B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Glass Compositions (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음.

Description

다층 과립
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 내부 서방성 층, 외부 급방성 층 및 상기 서방성 층과 상기 급방성 층 사이에 형성되고 경화유와 히드록시프로필 셀룰로스 또는 메틸 세룰로스를 포함하는 중간층으로 이루어지는 다층 과립.
  2. 제1항에 있어서, 중간층이 20 내지 90중량 퍼센트의 경화유와 1 내지 10중량 퍼센트의 히드록시프로필 셀룰로스 또는 메틸 셀룰로스를 포함하는 것을 특징으로 하는 과립.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890001165A 1988-02-03 1989-02-01 다층 과립 KR910004582B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP63023215A JP2643222B2 (ja) 1988-02-03 1988-02-03 多重層顆粒
JP63-23215 1988-02-03

Publications (2)

Publication Number Publication Date
KR890012636A true KR890012636A (ko) 1989-09-18
KR910004582B1 KR910004582B1 (ko) 1991-07-06

Family

ID=12104439

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890001165A KR910004582B1 (ko) 1988-02-03 1989-02-01 다층 과립

Country Status (11)

Country Link
US (1) US4994279A (ko)
EP (1) EP0327086B1 (ko)
JP (1) JP2643222B2 (ko)
KR (1) KR910004582B1 (ko)
CN (1) CN1031036C (ko)
AT (1) ATE75607T1 (ko)
CA (1) CA1337899C (ko)
DE (1) DE68901384D1 (ko)
ES (1) ES2031290T3 (ko)
PH (1) PH26515A (ko)
PT (1) PT89600B (ko)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2044246T3 (es) * 1989-02-11 1994-01-01 Bayer Ag Medicamentos con liberacion controlada del producto activo.
DE69101313T2 (de) * 1990-01-30 1994-06-30 Akzo Nv Gegenstand zur gesteuerten wirkstoffabgabe mit einem von einer wand völlig umschlossenen hohlraum und völlig oder teilweise mit einem oder mehreren wirkstoffen gefüllt.
US5126147A (en) * 1990-02-08 1992-06-30 Biosearch, Inc. Sustained release dosage form
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5478577A (en) 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
US5430021A (en) * 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
DE4443175A1 (de) * 1994-12-05 1996-06-13 Jenapharm Gmbh Neue pulsatile Arzneiform
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
ES2129356B1 (es) * 1997-03-26 2000-01-16 Pierre Fabre Iberica S A Forma farmaceutica de liberacion prolongada y procedimiento para su o btencion.
US6183482B1 (en) * 1997-10-01 2001-02-06 Scimed Life Systems, Inc. Medical retrieval basket with legs shaped to enhance capture and reduce trauma
TW477702B (en) 1997-10-23 2002-03-01 Dev Center Biotechnology Controlled release tacrine dosage form
EP0928610A1 (en) * 1998-01-08 1999-07-14 Development Center For Biotechnology Controlled release tacrine dosage form
UA69413C2 (uk) 1998-05-22 2004-09-15 Брістол-Майерс Сквібб Компані Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
UA73092C2 (uk) 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
JP2003509439A (ja) * 1999-09-14 2003-03-11 スミスクライン・ビーチャム・コーポレイション 水性コーティングされたビーズレットの製法
GB0007419D0 (en) * 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
EP2422773A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US20070224269A1 (en) * 2004-06-10 2007-09-27 Rubino Orapin P Controlled Release Pharmaceutical Formulation
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
KR20140079441A (ko) 2006-06-19 2014-06-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
EP2073797A2 (en) * 2006-10-11 2009-07-01 Alpharma, Inc. Pharmaceutical compositions
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
WO2009020595A2 (en) * 2007-08-03 2009-02-12 Shaklee Corporation Nutritional supplement system
US9763989B2 (en) 2007-08-03 2017-09-19 Shaklee Corporation Nutritional supplement system
US8323695B2 (en) * 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
IL199781A0 (en) * 2009-07-09 2010-05-17 Yohai Zorea Heat resistant probiotic compositions and healthy food comprising them
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20100266645A1 (en) * 2007-12-17 2010-10-21 Alfred Liang Pharmaceutical compositions
CA2709905A1 (en) * 2007-12-17 2009-06-25 Alfred Liang Abuse-resistant oxycodone composition
BR112013014044A2 (pt) 2010-12-06 2017-10-31 Degama Barrier Ltd composição, produto alimentício e processo para prepará-lo
US10543175B1 (en) 2013-05-17 2020-01-28 Degama Berrier Ltd. Film composition and methods for producing the same
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN106035323B (zh) * 2016-05-25 2018-12-11 广西南宁农事帮农业科技服务有限公司 一种缓释农药颗粒剂及其制备方法
CN107188722A (zh) * 2017-07-12 2017-09-22 山东棉花研究中心 一种组合式短季棉专用配方肥
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
NL109170C (ko) * 1958-02-03
NL270408A (ko) * 1960-10-20
UST861008I4 (en) * 1968-05-16 1969-04-01 Defensive publication
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
GB1594102A (en) * 1977-09-26 1981-07-30 Sankyo Co Ingestible coating compositions
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
JPS5770816A (en) * 1980-10-17 1982-05-01 Ono Pharmaceut Co Ltd Multilayered film preparation of prostagladin of prolonged action
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
JPS58134019A (ja) * 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンd↓3類組成物
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
US4572883A (en) * 1984-06-11 1986-02-25 Xerox Corporation Electrophotographic imaging member with charge injection layer
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
JPS6261916A (ja) * 1985-09-12 1987-03-18 Fujisawa Pharmaceut Co Ltd 持続性製剤
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒

Also Published As

Publication number Publication date
US4994279A (en) 1991-02-19
CN1031036C (zh) 1996-02-21
JP2643222B2 (ja) 1997-08-20
EP0327086A2 (en) 1989-08-09
PT89600B (pt) 1994-01-31
JPH01197433A (ja) 1989-08-09
PT89600A (pt) 1989-10-04
ES2031290T3 (es) 1992-12-01
DE68901384D1 (de) 1992-06-11
ATE75607T1 (de) 1992-05-15
PH26515A (en) 1992-08-07
CA1337899C (en) 1996-01-09
EP0327086B1 (en) 1992-05-06
CN1037082A (zh) 1989-11-15
EP0327086A3 (en) 1989-09-06
KR910004582B1 (ko) 1991-07-06

Similar Documents

Publication Publication Date Title
KR890012636A (ko) 다층 과립
KR920000315A (ko) 모다피닐의 용도
KR890012096A (ko) 다층 구동축
DE68905623T2 (de) Buchsenartiges hydraulisch gedaempftes motor- oder getriebelager.
AR001432A1 (es) Cilindro y horquilla de cambio.
KR900015891A (ko) 저투과성 호스의 제조방법
KR840005313A (ko) 관개 파이프
KR890013109A (ko) 난연성, 열가소성 탄성중합체 조성물
MX9201216A (es) Procedimiento para la fabricacion de 2-cloro-1,1,1,2-tetra fluoro etano y penta fluoro etano.
DE69003293D1 (de) Elastische, hydraulisch gedämpfte Buchse mit radialer Elastizität und Entkoppelung der Steifigkeiten.
KR900001343A (ko) 원적외선을 방사하는 세라믹 볼(Ball)
KR880013490A (ko) 함성수지 갓
KR890010184A (ko) 다층 비누
KR900015747A (ko) 간장관련 질병 치료제의 제조방법
KR900005979A (ko) 피레녹신의 안 현탁액
KR920021070A (ko) 도토리쿨(토토리음료)
KR900003682A (ko) 접착식 인화지
KR910004767A (ko) 용해하기 쉬운 젤라틴의 제법
KR900000219A (ko) 유치이용 기념품
KR970030745U (ko) 플라스틱재 클러치 마스터 실린더의 플랜지에의 부시 장착구조
KR920004230A (ko) 이륜승용차 조립식 확대 짐받이, 제작 사용 방법
KR880002778A (ko) 피복형 지속성 입상 비료의 제조방법
KR920019674A (ko) 무폐수 페놀수지 제조방법
KR910001098A (ko) 닭털 및 오리털의 원단화
KR910015471A (ko) 비행선(飛行線)

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20070625

Year of fee payment: 17

LAPS Lapse due to unpaid annual fee